TG THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tg Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2011 to Q2 2024.
  • Tg Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$2.27M, a 22.9% increase year-over-year.
  • Tg Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$6.07M, a 12.8% increase year-over-year.
  • Tg Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$7.57M, a 37.8% decline from 2022.
  • Tg Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$5.5M, a 65% decline from 2021.
  • Tg Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.33M, a 42.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$6.07M -$2.27M +$671K +22.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$6.74M -$1.41M +$832K +37.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$7.57M -$1.54M -$610K -65.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$6.96M -$854K +$1K +0.12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$6.96M -$2.94M -$1.37M -87.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$5.6M -$2.24M -$99K -4.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$5.5M -$931K -$540K -138% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$4.96M -$855K -$346K -68% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$4.61M -$1.57M -$564K -56.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$4.05M -$2.14M -$715K -50.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$3.33M -$391K +$1.05M +72.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$4.38M -$509K +$932K +64.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$5.31M -$1.01M +$1.03M +50.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$6.34M -$1.43M -$555K -63.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$5.79M -$1.44M +$175K +10.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$5.96M -$1.44M -$372K -34.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$5.59M -$2.04M -$1.37M -205% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$4.22M -$871K -$404K -86.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$3.82M -$1.61M -$2.66M -254% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$1.16M -$1.07M -$692K -184% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$469K -$669K -$872K -430% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $403K -$467K -$515K -1073% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $918K $1.04M +$868K +493% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $50K -$377K -$426K -869% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $476K $203K +$131K +182% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $345K $48K +$109K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $236K $176K -$178K -50.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $414K $49K -$45.4K -48.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $459K $72K -$52.4K -42.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $512K -$61K -$204K -143% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $716K $354K +$325K +1155% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $391K $94.4K -$75.2K -44.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $466K $124K +$116K +1381% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $350K $143K +$118K +471% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $231K $28.2K +$103K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $128K $170K +$181K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$53.6K $8.4K +$39.3K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$92.9K $25.1K -$32.8K -56.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$60.2K -$75.3K -$2.39M -103% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $2.33M -$11.8K -$103K -113% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $2.43M -$30.9K -$75.1K -170% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.51M $57.9K +$17.4K +43.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.49M $2.31M +$1.79M +346% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $694K $91.2K +$87.2K +2166% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $607K $44.2K -$487K -91.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-24
Q1 2013 $1.09M $40.4K +$51.6K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $1.04M $519K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 $4.03K +$4.03K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $531K +$531K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$11.2K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $0 Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.